| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40,883 |
34,039 |
$2.14M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,290 |
4,173 |
$459K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,981 |
2,790 |
$293K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,824 |
2,671 |
$289K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,586 |
1,505 |
$152K |
| 90670 |
|
1,999 |
1,939 |
$69K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,166 |
9,546 |
$49K |
| 90716 |
|
1,067 |
1,037 |
$43K |
| 92552 |
|
6,365 |
6,006 |
$35K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
485 |
478 |
$33K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,899 |
2,769 |
$21K |
| 90651 |
|
606 |
580 |
$18K |
| 90461 |
|
4,112 |
3,951 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,767 |
2,833 |
$12K |
| 90698 |
|
1,042 |
1,017 |
$7K |
| 87400 |
|
665 |
318 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
543 |
522 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,064 |
3,777 |
$4K |
| 90680 |
|
1,216 |
1,190 |
$4K |
| 90620 |
|
56 |
54 |
$4K |
| 99173 |
|
8,131 |
7,627 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
73 |
73 |
$3K |
| 90619 |
|
106 |
105 |
$2K |
| 90697 |
|
108 |
106 |
$2K |
| 0071A |
|
66 |
64 |
$2K |
| 90633 |
|
1,091 |
1,063 |
$2K |
| 0072A |
|
54 |
50 |
$2K |
| 87081 |
|
1,986 |
1,906 |
$2K |
| 90686 |
|
1,386 |
1,332 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
16 |
14 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
511 |
355 |
$878.37 |
| 90707 |
|
1,031 |
997 |
$859.56 |
| 99058 |
|
1,127 |
1,074 |
$686.22 |
| 90734 |
|
191 |
186 |
$681.62 |
| 99441 |
|
1,258 |
1,183 |
$673.99 |
| 90744 |
|
822 |
781 |
$552.89 |
| 90700 |
|
733 |
724 |
$546.38 |
| 87430 |
|
45 |
43 |
$253.25 |
| 99051 |
|
558 |
535 |
$230.37 |
| 90713 |
|
195 |
188 |
$178.01 |
| 94664 |
|
153 |
147 |
$147.59 |
| A7005 |
Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable |
140 |
133 |
$108.45 |
| 36416 |
|
1,184 |
1,047 |
$101.29 |
| 90688 |
|
273 |
262 |
$96.82 |
| 81000 |
|
429 |
405 |
$83.21 |
| 90715 |
|
54 |
54 |
$82.78 |
| 90687 |
|
303 |
299 |
$33.25 |
| Q3014 |
Telehealth originating site facility fee |
44 |
39 |
$25.64 |
| 90648 |
|
190 |
190 |
$25.25 |
| 99050 |
|
110 |
102 |
$22.85 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
158 |
149 |
$21.40 |
| H0049 |
Alcohol and/or drug screening |
12 |
12 |
$17.08 |
| 90696 |
|
58 |
48 |
$10.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
31 |
24 |
$1.65 |
| A7015 |
Aerosol mask, used with dme nebulizer |
128 |
123 |
$0.00 |
| 90677 |
|
32 |
31 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
19 |
12 |
$0.00 |
| 90662 |
|
29 |
28 |
$0.00 |
| 90621 |
|
12 |
12 |
$0.00 |